Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
1.880
-0.040 (-2.08%)
Nov 20, 2024, 4:00 PM EST - Market closed
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $8.16 million as of November 21, 2024. Its market cap has increased by 90.91% in one year.
Market Cap
8.16M
Enterprise Value
4.49M
1-Year Change
90.91%
Ranking
Category
Stock Price
$1.88
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $8.16M, a decrease of -96.06%. That is a compound annual growth rate of -74.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 8.16M | 208.63% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jaguar Health | 8.87M |
| Soligenix | 8.68M |
| Forte Biosciences | 8.65M |
| Syros Pharmaceuticals | 8.51M |
| IM Cannabis | 8.34M |
| ATI Physical Therapy | 8.29M |
| XWELL | 8.09M |
| Mustang Bio | 8.09M |